Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


04.07.2022

17 Ann Rheum Dis
3 Arthritis Res Ther
2 Clin Exp Rheumatol
1 Clin Rheumatol
1 Curr Opin Rheumatol
3 J Rheumatol
1 PLoS One
1 Rheumatol Int
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. ASSAN F, Seror R, Mariette X, Nocturne G, et al
    New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS.
    Ann Rheum Dis. 2021;80:e122.
    PubMed        

  2. WALLACE B, Washer L, Marder W, Kahlenberg JM, et al
    Patients with lupus with COVID-19: University of Michigan experience.
    Ann Rheum Dis. 2021;80:e35.
    PubMed        

  3. MONTI S, Montecucco C
    Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.
    Ann Rheum Dis. 2021;80:e40.
    PubMed        

  4. GUPTA L, Misra DP, Agarwal V, Balan S, et al
    Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al.
    Ann Rheum Dis. 2021;80:e47.
    PubMed        

  5. LIEW JW, Graef ER
    Rheumatic disease and COVID-19.
    Ann Rheum Dis. 2021;80:e43.
    PubMed        

  6. AKIYAMA S, Hamdeh S, Micic D, Sakuraba A, et al
    Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
    Ann Rheum Dis. 2021;80:384-391.
    PubMed         Abstract available

  7. BAER AN, Gottenberg JE, St Clair EW, Sumida T, et al
    Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial.
    Ann Rheum Dis. 2021;80:339-348.
    PubMed         Abstract available

  8. FELTEN R, Devauchelle-Pensec V, Seror R, Duffau P, et al
    Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial.
    Ann Rheum Dis. 2021;80:329-338.
    PubMed         Abstract available

  9. MATTHIJSSEN XME, Wouters F, Sidhu N, Niemantsverdriet E, et al
    Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study.
    Ann Rheum Dis. 2021;80:974-980.
    PubMed         Abstract available

  10. HAYER S, Vervoordeldonk MJ, Denis MC, Armaka M, et al
    'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models.
    Ann Rheum Dis. 2021;80:714-726.
    PubMed         Abstract available

  11. BOWER H, Frisell T, Di Giuseppe D, Delcoigne B, et al
    Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.
    Ann Rheum Dis. 2021;80:1086-1093.
    PubMed         Abstract available

  12. WANG H, Stewart S, Darlow B, Horgan B, et al
    Patient research partner involvement in rheumatology clinical trials: analysis of journal articles 2016-2020.
    Ann Rheum Dis. 2021;80:1095-1096.
    PubMed        

  13. NAKAMURA H, Tanaka T, Pranzatelli T, Ji Y, et al
    Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjogren's syndrome-like phenotype in mice.
    Ann Rheum Dis. 2021;80:1031-1039.
    PubMed         Abstract available

  14. ANSALONE C, Cole J, Chilaka S, Sunzini F, et al
    TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursors.
    Ann Rheum Dis. 2021;80:748-757.
    PubMed         Abstract available

  15. CROW MK
    Charles L Christian: model physician scientist and mentor.
    Ann Rheum Dis. 2021;80:685-688.
    PubMed        

  16. VALLEJO-YAGUE E, Keystone EC, Kandhasamy S, Micheroli R, et al
    Primary and secondary non-response: in need of operational definitions in observational studies.
    Ann Rheum Dis. 2021;80:961-964.
    PubMed        

  17. QIN Y, Cai ML, Jin HZ, Huang W, et al
    Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-alpha-mediated ERK1/2 and JAK-STAT1 pathways.
    Ann Rheum Dis. 2022 Jun 27. pii: ard-2022-222605. doi: 10.1136/ard-2022-222605.
    PubMed         Abstract available


    Arthritis Res Ther

  18. DAKKAK YJ, van Dijk BT, Jansen FP, Wisse LJ, et al
    Evidence for the presence of synovial sheaths surrounding the extensor tendons at the metacarpophalangeal joints: a microscopy study.
    Arthritis Res Ther. 2022;24:154.
    PubMed         Abstract available

  19. BERGMAN M, Tundia N, Martin N, Suboticki JL, et al
    Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
    Arthritis Res Ther. 2022;24:155.
    PubMed         Abstract available

  20. JUNG SM, Han M, Kim EH, Jung I, et al
    Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018.
    Arthritis Res Ther. 2022;24:157.
    PubMed         Abstract available


    Clin Exp Rheumatol

  21. SAKELLARIOU G, Carrara G, Zanetti A, Scire CA, et al
    Do we need Early Arthritis Clinics to counteract the excess of mortality in rheumatoid arthritis?
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18227.
    PubMed        

  22. WEMAN L, Vehmas J, Immonen J, Hannonen P, et al
    Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18494.
    PubMed         Abstract available


    Clin Rheumatol

  23. PHUKAN P, Barman B, Chengappa NK, Lynser D, et al
    Diffusion tensor imaging analysis of rheumatoid arthritis patients with neuropsychiatric features to determine the alteration of white matter integrity due to vascular events.
    Clin Rheumatol. 2022 Jun 25. pii: 10.1007/s10067-022-06262.
    PubMed         Abstract available


    Curr Opin Rheumatol

  24. IZNARDO H, Puig L
    Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes.
    Curr Opin Rheumatol. 2022;34:225-234.
    PubMed         Abstract available


    J Rheumatol

  25. YUN H, Xie F, Chen L, Yang S, et al
    Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
    J Rheumatol. 2021;48:992-1001.
    PubMed         Abstract available

  26. MCCOY SS, Bartels CM, Saldanha IJ, Bunya VY, et al
    National Sjogren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
    J Rheumatol. 2021;48:1029-1036.
    PubMed         Abstract available

  27. ORNETTI P, Guillier D, Jeudy G
    Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm.
    J Rheumatol. 2021;48:1103.
    PubMed        


    PLoS One

  28. GONI M, Basu N, Murray AD, Waiter GD, et al
    Brain predictors of fatigue in rheumatoid arthritis: A machine learning study.
    PLoS One. 2022;17:e0269952.
    PubMed         Abstract available


    Rheumatol Int

  29. BOYADZHIEVA V, Tachkov K, Stoilov N, Mitov K, et al
    Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
    Rheumatol Int. 2022 Jun 27. pii: 10.1007/s00296-022-05163.
    PubMed         Abstract available


    Scand J Rheumatol

  30. KRIJBOLDER DI, Verstappen M, Wouters F, Lard LR, et al
    Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.
    Scand J Rheumatol. 2022;51:284-290.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: